Non-surgical septal reduction therapy in hypertrophic cardiomyopathy

被引：6
|
作者：
Cooper, Robert M. [1 ]
Stables, Rodney H. [1 ]
机构：
[1] Liverpool Heart & Chest Hosp, Inst Cardiovasc Med & Sci, Liverpool L14 3PE, Merseyside, England
来源：
HEART | 2018年 / 104卷 / 01期
关键词：
LEFT-VENTRICULAR OUTFLOW; SUDDEN CARDIAC DEATH; COMPLETE HEART-BLOCK; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; MUSCULAR SUBAORTIC STENOSIS; TERM PROPRANOLOL THERAPY; HIGH-RISK PATIENTS; MONTHS FOLLOW-UP; OBSTRUCTIVE CARDIOMYOPATHY; MAGNETIC-RESONANCE;
D O I：
10.1136/heartjnl-2016-309952
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：73 / U235
页数：11
相关论文
共 50 条
  • [21] Non-surgical septal ablation (PTSMA) in patients with NYHA class IV and hypertrophic obstructive cardiomyopathy (HOCM)
    Seggewiss, H
    Faber, L
    Ziemssen, P
    Meyners, W
    CIRCULATION, 1999, 100 (18) : 515 - 515
  • [22] Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy
    Knight, C
    Sigwart, U
    HEART, 1996, 76 (01) : 92 - 92
  • [23] PULMONARY HYPERTENSION IN HYPERTROPHIC CARDIOMYOPATHY: EFFECT OF SEPTAL REDUCTION THERAPY
    Geske, Jeffrey B.
    Konecny, Tomas
    Ommen, Steve
    Nishimura, Rick
    Gersh, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1224 - E1224
  • [24] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [25] Mavacamten, an Alternative to Septal Reduction Therapy for Patients with Hypertrophic Cardiomyopathy
    Desai, Milind Y.
    Ali, Adel Hajj
    HEART INTERNATIONAL, 2023, 17 (01): : 2 - 4
  • [26] Long term follow up of hypertrophic cardiomyopathy patients treated with non surgical septal reduction
    Harrington, D
    Knight, C
    Sigwart, U
    CIRCULATION, 1999, 100 (18) : 76 - 76
  • [27] Tumor necrosis factor x is a potential mediator of pressure overload injury in patients with hypertrophic obstructive cardiomyopathy:: Effects of non-surgical septal reduction
    Torre-Amione, G
    Stetson, SS
    Youker, KA
    Lakkis, NM
    Spencer, WH
    Entman, ML
    Nagueh, SF
    CIRCULATION, 1999, 100 (18) : 128 - 128
  • [28] Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: Volume Still Matters for Septal Myectomy
    See, Vincent Y. Y.
    Wang, Libin
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (10):
  • [29] Electrophysiologic consequences of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    不详
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (11) : 1296 - 1296
  • [30] Reoperation Was an Effective Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy After Septal Reduction Therapy
    Zhang, Yang
    Zhu, Changsheng
    Song, Changpeng
    Yin, Kunlun
    Zhang, Jian
    Huang, Manyun
    Zheng, Xinxin
    Lu, Jie
    Fang, Xiaonan
    Zhou, Zhou
    Wang Shuiyun
    Huang, Xiaohong
    CIRCULATION, 2021, 144
12345